Ani Pharmaceuticals Inc financial data

Symbol
ANIP on Nasdaq
Industry
Pharmaceutical Preparations
Location
210 Main Street West, Baudette, MN
State of incorporation
DE
Fiscal year end
December 31
Former names
BIOSANTE PHARMACEUTICALS INC (to 7/18/2013), BEN ABRAHAM TECHNOLOGIES INC (to 12/23/1999)
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 380 % +10.4%
Quick Ratio 82.1 % -13.8%
Debt-to-equity 99.4 % -19.9%
Return On Equity 6.1 %
Return On Assets 2.98 %

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 824M USD +121%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 19.3M shares +9.23%
Weighted Average Number of Shares Outstanding, Diluted 19.3M shares +8.21%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 539M USD +34.3%
Research and Development Expense 38.8M USD +48.2%
Costs and Expenses 489M USD +27.9%
Operating Income (Loss) 50.2M USD +162%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 35.5M USD -144%
Income Tax Expense (Benefit) 8.49M USD
Net Income (Loss) Attributable to Parent 27M USD -137%
Earnings Per Share, Basic 1.2 USD/shares -147%
Earnings Per Share, Diluted 1.18 USD/shares -148%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 240M USD +48.5%
Accounts Receivable, after Allowance for Credit Loss, Current 166M USD -3.95%
Inventory, Net 125M USD +20.3%
Assets, Current 555M USD +20.9%
Deferred Income Tax Assets, Net 89.5M USD +9.82%
Property, Plant and Equipment, Net 51.6M USD +16.4%
Intangible Assets, Net (Excluding Goodwill) 183M USD -20.5%
Goodwill 28.2M USD 0%
Other Assets, Noncurrent 12.8M USD -17.8%
Assets 921M USD +7.15%
Accounts Payable, Current 48.7M USD +70.8%
Employee-related Liabilities, Current 16.1M USD +40.2%
Accrued Liabilities, Current 6.92M USD +29.6%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 140M USD +13.9%
Operating Lease, Liability, Noncurrent 4.11M USD +198%
Other Liabilities, Noncurrent 4.68M USD -1.1%
Liabilities 440M USD +3.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 8.33M USD -39.3%
Retained Earnings (Accumulated Deficit) -65M USD +28.1%
Stockholders' Equity Attributable to Parent 456M USD +11.3%
Liabilities and Equity 921M USD +7.15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 18.3M USD -14.7%
Net Cash Provided by (Used in) Financing Activities -19.7M USD -334%
Net Cash Provided by (Used in) Investing Activities 8.93M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7.48M USD -48.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 240M USD +48.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 7.95M USD +85.1%
Deferred Tax Assets, Valuation Allowance 400K USD 0%
Deferred Tax Assets, Gross 102M USD +11.3%
Operating Lease, Liability 5.67M USD +175%
Payments to Acquire Property, Plant, and Equipment 4.58M USD +95%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 21.6M USD +589%
Lessee, Operating Lease, Liability, to be Paid 6.66M USD +195%
Property, Plant and Equipment, Gross 77.5M USD +2.07%
Operating Lease, Liability, Current 1.56M USD +128%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.61M USD +85.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.97M USD +146%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 990K USD +410%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.29M USD +174%
Deferred Tax Assets, Operating Loss Carryforwards 2.9M USD -51.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1.67M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.29M USD +1348%
Additional Paid in Capital 532M USD +7.47%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 52.7M USD +3.95%
Depreciation, Depletion and Amortization 50.9M USD +14.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%